Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Carlsmed Inc (CARL)
Carlsmed Inc stock price live, this page displays NASDAQ CARL stock exchange data. View the CARL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Carlsmed Inc real time stock price chart below.
What Is the Carlsmed Inc Stock Price Today?
The Carlsmed Inc stock price today is 10.95.
What Is the Stock Symbol for Carlsmed Inc?
The stock ticker symbol for Carlsmed Inc is CARL.
Is CARL the Same as $CARL?
$CARL is a common way to refer to the Carlsmed Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Carlsmed Inc Trade On?
Carlsmed Inc is listed and trades on the NASDAQ stock exchange.
Is Carlsmed Inc a Good Stock to Buy?
Determining whether Carlsmed Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Carlsmed Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CARL quote. (ISIN: US14280C1053)
What Is the Carlsmed Inc Stock Price Today?
The Carlsmed Inc stock price today is 10.95.
What Is the Stock Symbol for Carlsmed Inc?
The stock ticker symbol for Carlsmed Inc is CARL.
Is CARL the Same as $CARL?
$CARL is a common way to refer to the Carlsmed Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Carlsmed Inc Trade On?
Carlsmed Inc is listed and trades on the NASDAQ stock exchange.
Is Carlsmed Inc a Good Stock to Buy?
Determining whether Carlsmed Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Carlsmed Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CARL quote. (ISIN: US14280C1053)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.44
11.05
52 wk Range
8.50
17.19
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.4411.05
52 wk Range
8.5017.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CARL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
19.20
Upside
+75.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Carlsmed reports 61% revenue growth in Q4 2025
- Investing.com
- Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 144 CARLSMED For: 2 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Carlsmed Inc Earnings Call Summary for Q4/2025
- Carlsmed reported 86% YoY revenue growth to $50.5M in 2025, with gross margin improving to 75.3% from 73.8% in 2024.
- Operating expenses surged 55% to $68.6M, widening GAAP net loss to $29.6M from $24.3M; adjusted EBITDA negative $28.4M.
- Company completed July 2025 IPO raising $100M+; stock fell 3.83% aftermarket to $13.06 despite strong revenue performance.
- Management projects 2026 revenue of $70.17M with mid-70s gross margins, citing path to profitability through operational leverage.
- Analysts set price targets of $17-$24, though rising expenses and widened losses present near-term profitability challenges.
Last Updated: 02/25/2026, 05:28 PM
Read Full TranscriptCompare CARL to Peers and Sector
Metrics to compare | CARL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCARLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.7x | −4.7x | −0.5x | |
PEG Ratio | −0.14 | −0.14 | 0.00 | |
Price / Book | 3.0x | 4.0x | 2.6x | |
Price / LTM Sales | 5.8x | 3.3x | 3.2x | |
Upside (Analyst Target) | 72.4% | 49.3% | 45.7% | |
Fair Value Upside | Unlock | 0.0% | 4.8% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.20
(+75.34% Upside)
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-0.32 / -0.35
Revenue / Forecast
15.2M / 14.9M
People Also Watch
FAQ
What Is the Carlsmed (CARL) Stock Price Today?
The Carlsmed stock price today is 10.95 USD.
What Stock Exchange Does Carlsmed Trade On?
Carlsmed is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Carlsmed?
The stock symbol for Carlsmed is "CARL."
What Is the Carlsmed Market Cap?
As of today, Carlsmed market cap is 279.08M USD.
What Is Carlsmed's Earnings Per Share (TTM)?
The Carlsmed EPS (TTM) is -2.12.
When Is the Next Carlsmed Earnings Date?
Carlsmed will release its next earnings report on May 05, 2026.
From a Technical Analysis Perspective, Is CARL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Carlsmed Stock Split?
Carlsmed has split 0 times.
How Many Employees Does Carlsmed Have?
Carlsmed has 127 employees.
What is the current trading status of Carlsmed (CARL)?
As of Apr 16, 2026, Carlsmed (CARL) is trading at a price of 10.95 USD, with a previous close of 10.44 USD. The stock has fluctuated within a day range of 10.44 USD to 11.05 USD, while its 52-week range spans from 8.50 USD to 17.19 USD.
What Is Carlsmed (CARL) Price Target According to Analysts?
The average 12-month price target for Carlsmed is 19.20 USD, with a high estimate of 24 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +75.34% Upside potential.
What Is the CARL Premarket Price?
CARL's last pre-market stock price is 10.60 USD. The pre-market share volume is 20.00, and the stock has decreased by 0.16, or 1.53%.
What Is the CARL After Hours Price?
CARL's last after hours stock price is 11.00 USD, the stock has decreased by 0.05, or 0.46%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.